Leukemia Clinical Trial
Official title:
Feasibility of Implementing Yoga Intervention for Adolescents at St. Jude Children's Research Hospital
Researchers at St. Jude Children's Research Hospital want to investigate the feasibility of
a yoga intervention for adolescents receiving treatment for lymphoma or leukemia.
Adolescents who participate in the program may experience improved physical and psychosocial
measures. Improvements in these areas may increase participation in meaningful activity and
improve quality of life.
Adolescents diagnosed with cancer may experience more fatigue, anxiety and pain during
treatment. Yoga is considered a complementary alternative medicine (CAM) that has been
implemented into some pediatric oncology rehabilitation programs and has been shown to be
beneficial in both inpatient and outpatient settings. It may decrease anxiety and increase
quality of life and hamstring flexibility in teens.
PRIMARY OBJECTIVE:
- To determine the feasibility of yoga intervention for adolescents during lymphoma and
leukemia treatment.
OTHER PRE-SPECIFIED OBJECTIVE:
- To obtain pilot data regarding efficacy of yoga on pain, quality of life, fatigue and
physical performance.
Those who consent to participate will participate in 60-minute yoga sessions 2-3 times per
week for 4-6 weeks. Only specified yoga poses will be implemented during the classes.
The study will be done in three parts: initial evaluation, yoga therapy, and follow-up
evaluations.
INITIAL EVALUATION: Participants will complete the PedsQL Cancer Module questionnaire and
the PedsQL Multidimensional Fatigue Scale questionnaire. Physical performance including
quadriceps strength, grip strength, hamstring flexibility, and balance, will be assessed.
YOGA THERAPY: The principal investigator (PI) is a certified yoga therapist (CYT) and is a
registered yoga teacher with 500 hours of training (RYT 500). Participants will take part in
a 60-minute yoga session conducted by the PI 2-3 times a week for 4-6 weeks, during which
time they must complete 8-12 yoga sessions. The yoga intervention includes these parts:
warm-up, strengthening, increasing hamstring flexibility, balance and relaxation. Yoga poses
will be used for each yoga session from a predetermined roster depending on individual
adolescent abilities. This will allow for a tailored but standardized yoga intervention.
Modifications including chairs, straps and blocks will be allowed to promote appropriate
form and use of these props will be recorded. Immediately before and after each yoga
session, the therapist will record pain with the verbal numeric pain scale.
FOLLOW-UP EVALUATIONS: After completion of the 4-6 weeks of yoga therapy, participants will
complete all assessments and physical performance measures that were done in the initial
evaluation.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05691608 -
MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2
|
N/A | |
| Recruiting |
NCT04092803 -
Virtual Reality as a Distraction Technique for Performing Lumbar Punctures in Children and Young Adu
|
N/A | |
| Active, not recruiting |
NCT02530463 -
Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome
|
Phase 2 | |
| Completed |
NCT00948064 -
Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
|
Phase 2 | |
| Completed |
NCT04474678 -
Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")
|
N/A | |
| Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03948529 -
RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation
|
Phase 2 | |
| Completed |
NCT01682226 -
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies
|
Phase 2 | |
| Completed |
NCT00003270 -
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT02723994 -
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
|
Phase 2 | |
| Terminated |
NCT02469415 -
Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS)
|
Phase 2 | |
| Recruiting |
NCT04856215 -
90Y-labelled Anti-CD66 ab in Childhood High Risk Leukaemia
|
Phase 2 | |
| Recruiting |
NCT06155188 -
Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia
|
N/A | |
| Completed |
NCT00001637 -
Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults
|
Phase 2 | |
| Active, not recruiting |
NCT04188678 -
Resiliency in Older Adults Undergoing Bone Marrow Transplant
|
N/A | |
| Completed |
NCT02910583 -
Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL)
|
Phase 2 | |
| Completed |
NCT01212926 -
Early Detection of Anthracycline Cardiotoxicity by Echocardiographic Analysis of Myocardial Deformation in 2D Strain
|
N/A | |
| Terminated |
NCT00014560 -
Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
| Recruiting |
NCT04977024 -
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
|
Phase 2 | |
| Recruiting |
NCT05866887 -
Insomnia Prevention in Children With Acute Lymphoblastic Leukemia
|
N/A |